Primary Care >
General Primary Care
News, opinions and meeting coverage in primary care.
Rituxan Offers Little Help for Sjogren's
Treatment for primary Sjogren's syndrome with the B-cell depleting antibody rituximab (Rituxan) failed to provide statistically significant improvements, despite the increasing evidence for B cells in the pathogenesis of this disorder, French researchers reported.
Feb 18, 2014
Ob/Gyns Uneasy With AHA's Take on Stroke in Pregnancy
NEW ORLEANS -- Recent guidelines from the American Heart Association on the management of stroke risk in pregnant women differ significantly from those issued by the American Congress of Obstetricians and Gynecologists, maternal-fetal medicine specialists said here.
Feb 10, 2014
Pay and Practice: Are Neurologists Primary Care Docs?
WASHINGTON -- Neurology isn't often mentioned in the same breath as primary care, but the American Academy of Neurology is again lobbying to gain that sobriquet -- this time to take advantage of a recent policy change that benefits primary care providers.
Jan 15, 2014
Droxidopa for OH Slammed by FDA Reviewers
SILVER SPRING, Md. -- Droxidopa (Northera) is getting a second look by an FDA advisory committee for the treatment of orthostatic hypotension stemming from neurological disorders like Parkinson's disease, but an agency review doesn't look promising for approval.
Jan 13, 2014
10 Questions: Rep. Phil Gingrey, MD (R-Ga.)
If you could change one thing about the healthcare system, what would it be? Eliminate Obamacare, says Rep. Phil Gingrey, MD (R-Ga.). That's his answer to just one of the 10 Questions the Ƶ staff is asking leading clinicians, researchers, and leaders in their community to get their personal views on their chosen profession. In this series we share their uncensored responses.
Jan 03, 2014
Killing Pain: Tramadol the 'Safe' Drug of Abuse
Almost 2 decades have passed since the FDA approved tramadol as a 'safe' opioid, but the intervening years provide evidence to question that 'safe' claim, as this latest investigation by John Fauber for the Milwaukee Journal Sentinel-Ƶ revealed.
Dec 22, 2013
OncoBlog: Driving the CAR to a Cancer Cure?
Is immunotherapy with chimeric antigen receptor (CAR)-directed T cells the "next big thing" in oncology? Presentations and discussion at a recent conference suggest the technology has considerable promise -- but will it qualify as a breakthrough? OncoBlog is a blog by the Ƶ
Medical Today staff for readers with an interest in oncology. This post comes from Charles Bankhead.
Dec 19, 2013